Alerts will be sent to your verified email
Verify EmailMOREPENLAB
Morepen Laboratories
|
IOL Chem & Pharma
|
Solara Active Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Global DMFs filed
|
211.0 . | n/a | n/a |
R&D as a % of Total Sales
|
0.87 % | 1.01 % | n/a |
Financials
|
|||
5 yr Average ROE
|
13.75 % | 8.9 % | -8.31 % |
5yr average Equity Multiplier
|
1.84 | 1.42 | 1.98 |
5yr Average Asset Turnover Ratio
|
1.34 | 0.99 | 0.55 |
5yr Avg Net Profit Margin
|
5.42 % | 6.28 % | -5.56 % |
Price to Book
|
2.74 | 1.74 | 2.67 |
P/E
|
26.82 | 29.13 | 119.02 |
5yr Avg Cash Conversion Cycle
|
21.38 Days | 37.81 Days | 115.03 Days |
Inventory Days
|
53.55 Days | 65.55 Days | 106.31 Days |
Days Receivable
|
63.5 Days | 86.45 Days | 125.38 Days |
Days Payable
|
98.41 Days | 100.1 Days | 142.19 Days |
5yr Average Interest Coverage Ratio
|
39.33 | 15.8 | 0.55 |
5yr Avg ROCE
|
15.84 % | 12.63 % | 3.01 % |
5yr Avg Operating Profit Margin
|
8.37 % | 10.64 % | 10.34 % |
5 yr average Debt to Equity
|
0.04 | 0.04 | 0.69 |
5yr CAGR Net Profit
|
23.42 % | -9.63 % | n/a |
5yr Average Return on Assets
|
7.36 % | 6.27 % | -2.61 % |
Shareholdings
|
|||
Promoter Holding
|
35.65 % | 52.62 % | 42.01 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 38.95 % |
Change in Promoter Holding (3 Yrs)
|
-1.09 % | 8.93 % | 1.61 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -1.56 % |
Morepen Laboratories
|
IOL Chem & Pharma
|
Solara Active Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|